drugset / Trial / NCT00080457

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

NCT00080457

Phase 3 Completed 240 enrolled Encysive Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of Thelin™ (sitaxsentan sodium) compared to placebo (sugar pill) in the treatment of patients with pulmonary arterial hypertension (PAH).

Timeline

Start
2003-05
Primary completion
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitaxentan Small molecule